Peering into the production process of China's inactivated COVID-19 vaccine
2021-01-24
Photo taken on July 15, 2020, through a microscope shows Vero cells cultivated in bioreactors at Sinovac Life Sciences Co., Ltd. in Beijing. [Photo/Xinhua]
A staff member cultivates Vero cells at Sinovac Life Sciences Co., Ltd. in Beijing, March 23, 2020. [Photo/Xinhua]
Staff members work at the high-level biosafety protective zone in the COVID-19 vaccine stock solution workshop soon to be put into operation at Sinovac Life Sciences Co., Ltd. in Beijing, July 15, 2020. [Photo/Xinhua]
A staff member checks parameter setup on the bioreactor used for Vero cell cultivation at the COVID-19 vaccine stock solution workshop during trial operation at Sinovac Life Sciences Co., Ltd. in Beijing, on July 15, 2021. [Photo/Xinhua]
A staff member carries out testing at the inactivated COVID-19 vaccine quality inspection lab of Sinovac Life Sciences Co., Ltd. in Beijing, Dec. 23, 2020. [Photo/Xinhua]
Staff members work at the high-level biosafety protective zone in the COVID-19 vaccine stock solution workshop soon to be put into operation at Sinovac Life Sciences Co., Ltd. in Beijing, July 15, 2020. [Photo/Xinhua]
A staff member performs random sample check on inactivated COVID-19 vaccine in vials at a packing line of Sinovac Life Sciences Co., Ltd. in Beijing, on Jan 6, 2021. [Photo/Xinhua]
A staff member checks tags on vials of inactivated COVID-19 vaccine at a packing line of Sinovac Life Sciences Co., Ltd. in Beijing, on Dec 23, 2020. [Photo/Xinhua]
Staff members supervise the operation of an automated packing line for inactivated COVID-19 vaccine at Sinovac Life Sciences Co., Ltd. in Beijing, on Jan 6, 2021. [Photo/Xinhua]
A staff member checks tags on prefilled syringes of inactivated COVID-19 vaccine at packing line of Sinovac Life Sciences Co., Ltd. in Beijing, March 23, 2020. [Photo/Xinhua]
